The Covaxin coronavirus vaccine, made in India, began its phase three human clinical trial at AIIMS in New Delhi on Thursday with Dr. MV Padma Srivastava, head of the main institute’s Neuroscience Center, and three other volunteers who received the first dose. AIIMS’s Dr. Srivastava was the first to receive …
Read More »Covaxin Phase-3 trial begins at AIIMS, key updates
